Manganese and the Brain

International Review of Neurobiology

Volumn 110, Issue , 2013, Pages 277-312

  Tuschl, Karin ^a   Mills, Philippa B ^a   Clayton, Peter T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Iron; Manganese; Manganism; Neurotoxicity; Parkinsonism; SLC30A10

Indexed keywords

4 AMINOBUTYRIC ACID; EDETATE CALCIUM DISODIUM; GLUTAMIC ACID; GLUTAMINE; IRON; MANGANESE; METAL ION; METHCATHINONE; NEUROTOXIN;

ARTICLE; BRAIN REGION; DETOXIFICATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; HOMEOSTASIS; HUMAN; HYPERMANGANESEMIA; IMAGE ANALYSIS; INBORN ERROR OF METABOLISM; INTOXICATION; IRON THERAPY; MANGANESE BLOOD LEVEL; MANGANESE TRANSPORT; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEPHROTOXICITY; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; SLC30A10 GENE; TOTAL PARENTERAL NUTRITION; TRANSPORT AT THE CELLULAR LEVEL;

IRON; MANGANESE; MANGANISM; NEUROTOXICITY; PARKINSONISM; SLC30A10;

ANIMALS; BRAIN; HOMEOSTASIS; HUMANS; MANGANESE; MANGANESE POISONING;

EID: 84887253119     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-410502-7.00013-2     Document Type: Chapter

References (196)

1. Abdalian R., Saqui O., Fernandes G., Allard J.P. Effects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition. Journal of Parenteral and Enteral Nutrition 2012, 37:538-543.
2. Abrams E., Lassiter J.W., Miller W.J., Neathery M.W., Gentry R.P., Scarth R.D. Absorption as a factor in manganese homeostasis. Journal of Animal Science 1976, 42:630-636.
3. Ahmed S.S., Santosh W. Metallomic profiling and linkage map analysis of early Parkinson's disease: A new insight to aluminum marker for the possible diagnosis. PLoS One 2010, 5:e11252.
4. Alves G., Thiebot J., Tracqui A., Delangre T., Guedon C., Lerebours E. Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition. Journal of Parenteral and Enteral Nutrition 1997, 21:41-45.
5. Anderson J.G., Fordahl S.C., Cooney P.T., Weaver T.L., Colyer C.L., Erikson K.M. Manganese exposure alters extracellular GABA, GABA receptor and transporter protein and mRNA levels in the developing rat brain. Neurotoxicology 2008, 29:1044-1053.
6. Angle C.R. Dimercaptosuccinic acid (DMSA): Negligible effect on manganese in urine and blood. Occupational and Environmental Medicine 1995, 52:846.
7. Aschner J.L., Aschner M. Nutritional aspects of manganese homeostasis. Molecular Aspects of Medicine 2005, 26:353-362.
8. Aschner M., Erikson K.M., Dorman D.C. Manganese dosimetry: Species differences and implications for neurotoxicity. Critical Reviews in Toxicology 2005, 35:1-32.
9. Aschner M., Gannon M., Kimelberg H.K. Manganese uptake and efflux in cultured rat astrocytes. Journal of Neurochemistry 1992, 58:730-735.
10. Aschner M., Guilarte T.R., Schneider J.S., Zheng W. Manganese: Recent advances in understanding its transport and neurotoxicity. Toxicology and Applied Pharmacology 2007, 221:131-147.
11. Au C., Benedetto A., Aschner M. Manganese transport in eukaryotes: The role of DMT1. Neurotoxicology 2008, 29:569-576.
12. Bartnikas T.B. Known and potential roles of transferrin in iron biology. Biometals 2012, 25:677-686.
13. Behrens M.I., Bruggemann N., Chana P., Venegas P., Kagi M., Parrao T., et al. Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations. Movement Disorders 2010, 25:1929-1937.
14. Bekiesinska-Figatowska M., Mierzewska H., Jurkiewicz E. Basal ganglia lesions in children and adults. European Journal of Radiology 2013, 82:837-849.
15. Benedetto A., Au C., Avila D.S., Milatovic D., Aschner M. Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genetics 2010, 6:1-18.
16. Bosomworth H.J., Thornton J.K., Coneyworth L.J., Ford D., Valentine R.A. Efflux function, tissue-specific expression and intracellular trafficking of the Zn transporter ZnT10 indicate roles in adult Zn homeostasis. Metallomics 2012, 4:771-779.
17. Bouchard M.F., Sauve S., Barbeau B., Legrand M., Brodeur M.E., Bouffard T., et al. Intellectual impairment in school-age children exposed to manganese from drinking water. Environmental Health Perspectives 2011, 119:138-143.
18. Bradberry S., Vale A. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning. Clinical Toxicology (Philadelphia, PA) 2009, 47:841-858.
19. Britton A.A., Cotzias G.C. Dependence of manganese turnover on intake. American Journal of Physiology 1966, 211:203-206.
20. Brna P., Gordon K., Dooley J.M., Price V. Manganese toxicity in a child with iron deficiency and polycythemia. Journal of Child Neurology 2011, 26:891-894.
21. Brouillet E.P., Shinobu L., McGarvey U., Hochberg F., Beal M.F. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Experimental Neurology 1993, 120:89-94.
22. Burdo J.R., Menzies S.L., Simpson I.A., Garrick L.M., Garrick M.D., Dolan K.G., et al. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. Journal of Neuroscience Research 2001, 66:1198-1207.
23. Burjonrappa S.C., Miller M. Role of trace elements in parenteral nutrition support of the surgical neonate. Journal of Pediatric Surgery 2012, 47:760-771.
24. Burkhard P.R., Delavelle J., Du P.R., Spahr L. Chronic parkinsonism associated with cirrhosis: A distinct subset of acquired hepatocerebral degeneration. Archives of Neurology 2003, 60:521-528.
25. Butterworth R.F. Complications of cirrhosis III. Hepatic encephalopathy. Journal of Hepatology 2000, 32:171-180.
26. Butterworth R.F. Parkinsonism in cirrhosis: Pathogenesis and current therapeutic options. Metabolic Brain Disease 2012, 28:261-267.
27. Butterworth R.F., Spahr L., Fontaine S., Layrargues G.P. Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metabolic Brain Disease 1995, 10:259-267.
28. Calne D.B., Chu N.S., Huang C.C., Lu C.S., Olanow W. Manganism and idiopathic parkinsonism: Similarities and differences. Neurology 1994, 44:1583-1586.
29. Cersosimo M.G., Koller W.C. The diagnosis of manganese-induced parkinsonism. Neurotoxicology 2006, 27:340-346.
30. Chakraborty S., Aschner M. Altered manganese homeostasis: Implications for BLI-3-dependent dopaminergic neurodegeneration and SKN-1 protection in C. elegans. Journal of Trace Elements in Medicine and Biology 2012, 26:183-187.
31. Chalela J.A., Bonillha L., Neyens R., Hays A. Manganese encephalopathy: An under-recognized condition in the intensive care unit. Neurocritical Care 2011, 14:456-458.
32. Chiesi M., Inesi G. Adenosine 5'-triphosphate dependent fluxes of manganese and and hydrogen ions in sarcoplasmic reticulum vesicles. Biochemistry 1980, 19:2912-2918.
33. Chua A.C., Morgan E.H. Manganese metabolism is impaired in the Belgrade laboratory rat. Journal of Comparative Physiology B 1997, 167:361-369.
34. Cockell K.A., Bonacci G., Belonje B. Manganese content of soy or rice beverages is high in comparison to infant formulas. Journal of the American College of Nutrition 2004, 23:124-130.
35. Coelho P., Costa S., Silva S., Walter A., Ranville J., Sousa A.C., et al. Metal(loid) levels in biological matrices from human populations exposed to mining contamination-Panasqueira mine (Portugal). Journal of Toxicology and Environmental Health, Part A 2012, 75:893-908.
36. Cordova F.M., Aguiar A.S., Peres T.V., Lopes M.W., Goncalves F.M., Pedro D.Z., et al. Manganese-exposed developing rats display motor deficits and striatal oxidative stress that are reversed by Trolox. Archives of Toxicology 2013, 87:1231-1244.
37. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. British Annals of Medicine Pharmacy, Vital Statistics, and General Science 1837, 1:41-42.
38. Crossgrove J.S., Allen D.D., Bukaveckas B.L., Rhineheimer S.S., Yokel R.A. Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of managanese citrate as well as manganese and manganese transferrin. Neurotoxicology 2003, 24:3-13.
39. Crossgrove J.S., Yokel R.A. Manganese distribution across the blood-brain barrier III. The divalent metal transporter-1 is not the major mechanism mediating brain manganese uptake. Neurotoxicology 2004, 25:451-460.
40. Crossgrove J.S., Yokel R.A. Manganese distribution across the blood-brain barrier. IV. Evidence for brain influx through store-operated calcium channels. Neurotoxicology 2005, 26:297-307.
41. Davidsson L., Cederblad A., Lonnerdal B., Sandstrom B. The effect of individual dietary components on manganese absorption in humans. American Journal of Clinical Nutrition 1991, 54:1065-1070.
42. Davis C.D., Wolf T.L., Greger J.L. Varying levels of manganese and iron affect absorption and gut endogenous losses of manganese by rats. Journal of Nutrition 1992, 122:1300-1308.
43. Delnooz C.C., Wevers R.A., Quadri M., Clayton P.T., Mills P.B., Tuschl K., et al. Phenotypic variability in a dystonia family with mutations in the manganese transporter gene. Movement Disorders 2013, 28:685-686.
44. Dobson A.W., Erikson K.M., Aschner M. Manganese neurotoxicity. Annals of the New York Academy of Sciences 2004, 1012:115-128.
45. Donaldson J., McGregor D., LaBella F. Manganese neurotoxicity: A model for free radical mediated neurodegeneration?. Canadian Journal of Physiology and Pharmacology 1982, 60:1398-1405.
46. Dorman D.C., Andersen M.E., Roper J.M., Taylor M.D. Update on a pharmacokinetic-centric alternative tier II program for MMT-part I: Program implementation and lessons learned. Journal of Toxicology 2012, 2012:946742.
47. Dorman D.C., Struve M.F., Marshall M.W., Parkinson C.U., James R.A., Wong B.A. Tissue manganese concentrations in young male rhesus monkeys following subchronic manganese sulfate inhalation. Toxicological Sciences 2006, 92:201-210.
48. Ebert B.L., Bunn H.F. Regulation of the erythropoietin gene. Blood 1999, 94:1864-1877.
49. Erikson K.M., Suber R.L., Aschner M. Glutamate/aspartate transporter (GLAST), taurine transporter and metallothionein mRNA levels are differentially altered in astrocytes exposed to manganese chloride, manganese phosphate or manganese sulfate. Neurotoxicology 2002, 23:281-288.
50. Erikson K.M., Thompson K., Aschner J., Aschner M. Manganese neurotoxicity: A focus on the neonate. Pharmacology and Therapeutics 2007, 113:369-377.
51. Farina M., Avila D.S., da Rocha J.B., Aschner M. Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury. Neurochemistry International 2012, 62:575-594.
52. Fell J.M., Reynolds A.P., Meadows N., Khan K., Long S.G., Quaghebeur G., et al. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 1996, 347:1218-1221.
53. Fernandez-Rodriguez R., Contreras A., De Villoria J.G., Grandas F. Acquired hepatocerebral degeneration: Clinical characteristics and MRI findings. European Journal of Neurology 2010, 17:1463-1470.
54. Ferrara J., Jankovic J. Acquired hepatocerebral degeneration. Journal of Neurology 2009, 256:320-332.
55. Filipov N.M., Dodd C.A. Role of glial cells in manganese neurotoxicity. Journal of Applied Toxicology 2012, 32:310-317.
56. Finkelstein M.M., Jerrett M. A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. Environmental Research 2007, 104:420-432.
57. Fitsanakis V.A., Zhang N., Avison M.J., Erikson K.M., Gore J.C., Aschner M. Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicological Sciences 2011, 120:146-153.
58. Fitsanakis V.A., Zhang N., Garcia S., Aschner M. Manganese (Mn) and iron (Fe): Interdependency of transport and regulation. Neurotoxicity Research 2010, 18:124-131.
59. Fordahl S.C., Anderson J.G., Cooney P.T., Weaver T.L., Colyer C.L., Erikson K.M. Manganese exposure inhibits the clearance of extracellular GABA and influences taurine homeostasis in the striatum of developing rats. Neurotoxicology 2010, 31:639-646.
60. Friedman B.J., Freeland-Graves J.H., Bales C.W., Behmardi F., Shorey-Kutschke R.L., Willis R.A., et al. Manganese balance and clinical observations in young men fed a manganese-deficient diet. Journal of Nutrition 1987, 117:133-143.
61. Fujishiro H., Yano Y., Takada Y., Tanihara M., Himeno S. Roles of ZIP8, ZIP14, and DMT1 in transport of cadmium and manganese in mouse kidney proximal tubule cells. Metallomics 2012, 4:700-708.
62. Fukushima T., Tan X., Luo Y., Kanda H. Relationship between blood levels of heavy metals and Parkinson's disease in China. Neuroepidemiology 2010, 34:18-24.
63. Garcia S.J., Gellein K., Syversen T., Aschner M. Iron deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. Toxicological Sciences 2007, 95:205-214.
64. 2+ sequestration by mitochondria and inhibition of oxidative phosphorylation. Toxicology and Applied Pharmacology 1992, 115:1-5.
65. Gianutsos G., Morrow G.R., Morris J.B. Accumulation of manganese in rat brain following intranasal administration. Fundamental and Applied Toxicology 1997, 37:102-105.
66. Girijashanker K., He L., Soleimani M., Reed J.M., Li H., Liu Z., et al. Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: Similarities to the ZIP8 transporter. Molecular Pharmacology 2008, 73:1413-1423.
67. Gitler A.D., Chesi A., Geddie M.L., Strathearn K.E., Hamamichi S., Hill K.J., et al. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nature Genetics 2009, 41:308-315.
68. Goldstein S., Meyerstein D., Czapski G. The Fenton reagents. Free Radical Biology & Medicine 1993, 15:435-445.
69. Gomes da C.A., Madeira V.M. Magnesium and manganese ions modulate Ca2+ uptake and its energetic coupling in sarcoplasmic reticulum. Archives of Biochemistry and Biophysics 1986, 249:199-206.
70. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., Brown G.G., et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997, 48:650-658.
71. Gorell J.M., Johnson C.C., Rybicki B.A., Peterson E.L., Kortsha G.X., Brown G.G., et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 1999, 20:239-247.
72. Gospe S.M., Caruso R.D., Clegg M.S., Keen C.L., Pimstone N.R., Ducore J.M., et al. Paraparesis, hypermanganesaemia, and polycythaemia: A novel presentation of cirrhosis. Archives of Disease in Childhood 2000, 83:439-442.
73. Gruenheid S., Canonne-Hergaux F., Gauthier S., Hackam D.J., Grinstein S., Gros P. The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. Journal of Experimental Medicine 1999, 189:831-841.
74. Guilarte T.R. Manganese and Parkinson's disease: A critical review and new findings. Ciência & Saúde Coletiva 2011, 16:4549-4566.
75. Guilarte T.R., Burton N.C., McGlothan J.L., Verina T., Zhou Y., Alexander M., et al. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): Implications to manganese-induced parkinsonism. Journal of Neurochemistry 2008, 107:1236-1247.
76. Guilarte T.R., McGlothan J.L., Degaonkar M., Chen M.K., Barker P.B., Syversen T., et al. Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: A 1H-MRS and MRI study. Toxicological Sciences 2006, 94:351-358.
77. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388:482-488.
78. Gunter T.E., Gerstner B., Gunter K.K., Malecki J., Gelein R., Valentine W.M., et al. Manganese transport via the transferrin mechanism. Neurotoxicology 2012, 34C:118-127.
79. HaMai D., Bondy S.C. Oxidative basis of manganese neurotoxicity. Annals of the New York Academy of Sciences 2004, 1012:129-141.
80. Hardy G. Manganese in parenteral nutrition: Who, when, and why should we supplement?. Gastroenterology 2009, 137:S29-S35.
81. Hauser R.A., Zesiewicz T.A., Martinez C., Rosemurgy A.S., Olanow C.W. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Canadian Journal of Neurological Sciences 1996, 23:95-98.
82. Hazell A.S., Normandin L., Norenberg M.D., Kennedy G., Yi J.H. Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neuroscience Letters 2006, 396:167-171.
83. He L., Girijashanker K., Dalton T.P., Reed J., Li H., Soleimani M., et al. ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: Characterization of transporter properties. Molecular Pharmacology 2006, 70:171-180.
84. Heilig E.A., Thompson K.J., Molina R.M., Ivanov A.R., Brain J.D., Wessling-Resnick M. Manganese and iron transport across pulmonary epithelium. American Journal of Physiology. Lung Cellular and Molecular Physiology 2006, 290:L1247-L1259.
85. Herrero H.E., Discalzi G., Valentini C., Venturi F., Chio A., Carmellino C., et al. Follow-up of patients affected by manganese-induced parkinsonism after treatment with CaNa2EDTA. Neurotoxicology 2006, 27:333-339.
86. Higashi Y., Asanuma M., Miyazaki I., Hattori N., Mizuno Y., Ogawa N. Parkin attenuates manganese-induced dopaminergic cell death. Journal of Neurochemistry 2004, 89:1490-1497.
87. Hozumi I., Hasegawa T., Honda A., Ozawa K., Hayashi Y., Hashimoto K., et al. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. Journal of Neurological Sciences 2011, 303:95-99.
88. Hsieh C.T., Liang J.S., Peng S.S., Lee W.T. Seizure associated with total parenteral nutrition-related hypermanganesemia. Pediatric Neurology 2007, 36:181-183.
89. Huang C.C. Parkinsonism induced by chronic manganese intoxication-An experience in Taiwan. Chang Gung Medical Journal 2007, 30:385-395.
90. Huang C.C., Chu N.S., Lu C.S., Calne D.B. Cock gait in manganese intoxication. Movement Disorders 1997, 12:807-808.
91. Huang C.C., Lu C.S., Chu N.S., Hochberg F., Lilienfeld D., Olanow W., et al. Progression after chronic manganese exposure. Neurology 1993, 43:1479-1483.
92. Huang E., Ong W.Y., Connor J.R. Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience 2004, 128:487-496.
93. Huang P., Chen C., Wang H., Li G., Jing H., Han Y., et al. Manganese effects in the liver following subacute or subchronic manganese chloride exposure in rats. Ecotoxicology and Environmental Safety 2011, 74:615-622.
94. Jiang Y.M., Mo X.A., Du F.Q., Fu X., Zhu X.Y., Gao H.Y., et al. Effective treatment of manganese-induced occupational parkinsonism with p-aminosalicylic acid: A case of 17-year follow-up study. Journal of Occupational and Environmental Medicine 2006, 48:644-649.
95. Kafritsa Y., Fell J., Long S., Bynevelt M., Taylor W., Milla P. Long-term outcome of brain manganese deposition in patients on home parenteral nutrition. Archives of Disease in Childhood 1998, 79:263-265.
96. Kannurpatti S.S., Joshi P.G., Joshi N.B. Calcium sequestering ability of mitochondria modulates influx of calcium through glutamate receptor channel. Neurochemical Research 2000, 25:1527-1536.
97. Keen C.L., Ensunsa J.L., Watson M.H., Baly D.L., Donovan S.M., Monaco M.H., et al. Nutritional aspects of manganese from experimental studies. Neurotoxicology 1999, 20:213-223.
98. Khan K., Wasserman G.A., Liu X., Ahmed E., Parvez F., Slavkovich V., et al. Manganese exposure from drinking water and children's academic achievement. Neurotoxicology 2012, 33:91-97.
99. Kikuchi A. An 8-year-old boy presenting with progressive extrapyramidal symptoms during total parenteral nutrition. No to Hattatsu 2009, 41:325-326.
100. Klos K.J., Chandler M., Kumar N., Ahlskog J.E., Josephs K.A. Neuropsychological profiles of manganese neurotoxicity. European Journal of Neurology 2006, 13:1139-1141.
101. Knopfel M., Zhao L., Garrick M.D. Transport of divalent transition-metal ions is lost in small-intestinal tissue of b/b Belgrade rats. Biochemistry 2005, 44:3454-3465.
102. Koller W.C., Lyons K.E., Truly W. Effect of levodopa treatment for parkinsonism in welders: A double-blind study. Neurology 2004, 62:730-733.
103. Komaki H., Maisawa S., Sugai K., Kobayashi Y., Hashimoto T. Tremor and seizures associated with chronic manganese intoxication. Brain & Development 1999, 21:122-124.
104. Krachler M., Rossipal E., Irgolic K.J. Trace elements in formulas based on cow and soy milk and in Austrian cow milk determined by inductively coupled plasma mass spectrometry. Biological Trace Element Research 1998, 65:53-74.
105. Kumar N., Boeve B.F., Cowl C.T., Ellison J.W., Kamath P.S., Swanson K.L. Hypermanganesemia, hereditary hemorrhagic telangiectasia, brain abscess: The hepatic connection. Neurology 2008, 71:1118-1119.
106. Leavens T.L., Rao D., Andersen M.E., Dorman D.C. Evaluating transport of manganese from olfactory mucosa to striatum by pharmacokinetic modeling. Toxicological Sciences 2007, 97:265-278.
107. Lebda M.A., El-Neweshy M.S., El-Sayed Y.S. Neurohepatic toxicity of subacute manganese chloride exposure and potential chemoprotective effects of lycopene. Neurotoxicology 2012, 33:98-104.
108. Leitch S., Feng M., Muend S., Braiterman L.T., Hubbard A.L., Rao R. Vesicular distribution of secretory pathway Ca(2)+-ATPase isoform 1 and a role in manganese detoxification in liver-derived polarized cells. Biometals 2011, 24:159-170.
109. Levin O.S. "Ephedron" encephalopathy. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 2005, 105:12-20.
110. London R.E., Toney G., Gabel S.A., Funk A. Magnetic resonance imaging studies of the brains of anesthetized rats treated with manganese chloride. Brain Research Bulletin 1989, 23:229-235.
111. Lucaciu C.M., Dragu C., Copaescu L., Morariu V.V. Manganese transport through human erythrocyte membranes. An EPR study. Biochimica et Biophysica Acta 1997, 1328:90-98.
112. Lucchini R.G., Martin C.J., Doney B.C. From manganism to manganese-induced parkinsonism: A conceptual model based on the evolution of exposure. Neuromolecular Medicine 2009, 11:311-321.
113. Madejczyk M.S., Ballatori N. The iron transporter ferroportin can also function as a manganese exporter. Biochimica et Biophysica Acta 2012, 1818:651-657.
114. Malecki E.A., Radzanowski G.M., Radzanowski T.J., Gallaher D.D., Greger J.L. Biliary manganese excretion in conscious rats is affected by acute and chronic manganese intake but not by dietary fat. Journal of Nutrition 1996, 126:489-498.
115. Martinez-Finley E.J., Gavin C.E., Aschner M., Gunter T.E. Manganese neurotoxicity and the role of reactive oxygen species. Free Radical Biology & Medicine 2013, 62:65-75.
116. Masumoto K., Suita S., Taguchi T., Yamanouchi T., Nagano M., Ogita K., et al. Manganese intoxication during intermittent parenteral nutrition: Report of two cases. Journal of Parenteral and Enteral Nutrition 2001, 25:95-99.
117. McDougall S.A., Reichel C.M., Farley C.M., Flesher M.M., Der-Ghazarian T., Cortez A.M., et al. Postnatal manganese exposure alters dopamine transporter function in adult rats: Potential impact on nonassociative and associative processes. Neuroscience 2008, 154:848-860.
118. Meissner W., Tison F. Acquired hepatocerebral degeneration. Handbook of Clinical Neurology 2011, 100:193-197.
119. Moreno J.A., Sullivan K.A., Carbone D.L., Hanneman W.H., Tjalkens R.B. Manganese potentiates nuclear factor-kappaB-dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways. Journal of Neuroscience Research 2008, 86:2028-2038.
120. Mousseau D.D., Perney P., Layrargues G.P., Butterworth R.F. Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neuroscience Letters 1993, 162:192-196.
121. 2+ efflux and protects against toxicity. Heilkunde-Heilwege 2011, 108:858-863.
122. Myers J.E., Fine J., Ormond-Brown D., Fry J., Thomson A., Thompson M.L. Estimating the prevalence of clinical manganism using a cascaded screening process in a South African manganese smelter. Neurotoxicology 2009, 30:934-940.
123. Nagatomo S., Umehara F., Hanada K., Nobuhara Y., Takenaga S., Arimura K., et al. Manganese intoxication during total parenteral nutrition: Report of two cases and review of the literature. Journal of Neurological Sciences 1999, 162:102-105.
124. Nelson K., Golnick J., Korn T., Angle C. Manganese encephalopathy: Utility of early magnetic resonance imaging. British Journal of Industrial Medicine 1993, 50:510-513.
125. Nolte W., Wiltfang J., Schindler C.G., Unterberg K., Finkenstaedt M., Niedmann P.D., et al. Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. Journal of Hepatology 1998, 29:443-449.
126. Papapetropoulos S., Tzakis A., Sengun C., Reddy C., Boukas K., Zitser J., et al. Case of pediatric acquired chronic hepatocerebral degeneration. Pediatric Neurology 2008, 38:67-70.
127. Park H.K., Kim S.M., Choi C.G., Lee M.C., Chung S.J. Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration. Movement Disorders 2008, 23:768-770.
128. Penland J.G., Johnson P.E. Dietary calcium and manganese effects on menstrual cycle symptoms. American Journal of Obstetrics and Gynecology 1993, 168:1417-1423.
129. Pinto R.B., Froehlich P.E., Pitrez E.H., Bragatti J.A., Becker J., Cornely A.F., et al. MR findings of the brain in children and adolescents with portal hypertension and the relationship with blood manganese levels. Neuropediatrics 2010, 41:12-17.
130. Pomier-Layrargues G., Spahr L., Butterworth R.F. Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 1995, 345:735.
131. Prabhakaran K., Ghosh D., Chapman G.D., Gunasekar P.G. Molecular mechanism of manganese exposure-induced dopaminergic toxicity. Brain Research Bulletin 2008, 76:361-367.
132. Quadri M., Federico A., Zhao T., Breedveld G.J., Battisti C., Delnooz C., et al. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. American Journal of Human Genetics 2012, 90:467-477.
133. Racette B.A., Aschner M., Guilarte T.R., Dydak U., Criswell S.R., Zheng W. Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology 2012, 33:881-886.
134. Rahelic D., Kujundzic M., Romic Z., Brkic K., Petrovecki M. Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis. Collegium Antropologicum 2006, 30:523-528.
135. Rao K.V., Norenberg M.D. Manganese induces the mitochondrial permeability transition in cultured astrocytes. Journal of Biological Chemistry 2004, 279:32333-32338.
136. Rentschler G., Covolo L., Haddad A.A., Lucchini R.G., Zoni S., Broberg K. ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese. Neurotoxicology 2012, 33:697-702.
137. Ribeiro R.T., Dos Santos-Neto D., Braga-Neto P., Barsottini O.G. Inherited manganism. Clinical Neurology and Neurosurgery 2013, 115:1536-1538.
138. Rivera-Mancia S., Rios C., Montes S. Manganese accumulation in the CNS and associated pathologies. Biometals 2011, 24:811-825.
139. Rodier J. Manganese poisoning in Moroccan miners. British Journal of Industrial Medicine 1955, 12:21-35.
140. Roels H.A., Bowler R.M., Kim Y., Claus H.B., Mergler D., Hoet P., et al. Manganese exposure and cognitive deficits: A growing concern for manganese neurotoxicity. Neurotoxicology 2012, 33:872-880.
141. Rose C., Butterworth R.F., Zayed J., Normandin L., Todd K., Michalak A., et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999, 117:640-644.
142. Roth J.A. Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination. Biological Research 2006, 39:45-57.
143. Roth J.A. Are there common biochemical and molecular mechanisms controlling manganism and parkinsonism. Neuromolecular Medicine 2009, 11:281-296.
144. Roth J.A., Ganapathy B., Ghio A.J. Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin. Toxicology In Vitro 2012, 26:1143-1149.
145. Roth J.A., Li Z., Sridhar S., Khoshbouei H. The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells. Neurotoxicology 2013, 35:121-128.
146. Roth J.A., Singleton S., Feng J., Garrick M., Paradkar P.N. Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1. Journal of Neurochemistry 2010, 113:454-464.
147. Roth J.A., Sridhar S., Singleton S.T. Effect of glutamate and riluzole on manganese-induced apoptotic cell signaling in neuronally differentiated mouse P19 cells. Neurochemistry International 2012, 61:25-33.
148. Sacher A., Cohen A., Nelson N. Properties of the mammalian and yeast metal-ion transporters DCT1 and Smf1p expressed in Xenopus laevis oocytes. Journal of Experimental Biology 2001, 204:1053-1061.
149. Sanchez B., Casalots-Casado J., Quintana S., Arroyo A., Martin-Fumado C., Galtes I. Fatal manganese intoxication due to an error in the elaboration of Epsom salts for a liver cleansing diet. Forensic Science International 2012, 223:e1-e4.
150. Sanotsky Y., Lesyk R., Fedoryshyn L., Komnatska I., Matviyenko Y., Fahn S. Manganic encephalopathy due to "ephedrone" abuse. Movement Disorders 2007, 22:1337-1343.
151. Santos P.C., Dinardo C.L., Cancado R.D., Schettert I.T., Krieger J.E., Pereira A.C. Non-HFE hemochromatosis. Revista Brasileira de Hematologia e Hemoterapia 2012, 34:311-316.
152. Scassellati C., Bonvicini C., Faraone S.V., Gennarelli M. Biomarkers and attention-deficit/hyperactivity disorder: A systematic review and meta-analyses. Journal of the American Academy of Child and Adolescent Psychiatry 2012, 51:1003-1019.
153. 2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2. Biochemical and Biophysical Research Communications 2009, 383:198-202.
154. Selikhova M., Fedoryshyn L., Matviyenko Y., Komnatska I., Kyrylchuk M., Krolicki L., et al. Parkinsonism and dystonia caused by the illicit use of ephedrone-A longitudinal study. Movement Disorders 2008, 23:2224-2231.
155. 2+ pumps. Journal of Neurochemistry 2007, 103:1009-1018.
156. Settivari R., Levora J., Nass R. The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in Caenorhabditis elegans models of manganism and Parkinson disease. Journal of Biological Chemistry 2009, 284:35758-35768.
157. Seve M., Chimienti F., Devergnas S., Favier A. In silico identification and expression of SLC30 family genes: An expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression. BMC Genomics 2004, 5:32.
158. Sidoryk-Wegrzynowicz M., Lee E., Albrecht J., Aschner M. Manganese disrupts astrocyte glutamine transporter expression and function. Journal of Neurochemistry 2009, 110:822-830.
159. Sidoryk-Wegrzynowicz M., Lee E., Mingwei N., Aschner M. Disruption of astrocytic glutamine turnover by manganese is mediated by the protein kinase C pathway. Glia 2011, 59:1732-1743.
160. Sikk K., Haldre S., Aquilonius S.M., Asser A., Paris M., Roose A., et al. Manganese-induced parkinsonism in methcathinone abusers: Bio-markers of exposure and follow-up. European Journal of Neurology 2013, 20:915-920.
161. Sikk K., Taba P., Haldre S., Bergquist J., Nyholm D., Askmark H., et al. Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure. Acta Neurologica Scandinavica 2010, 121:237-243.
162. Sikk K., Taba P., Haldre S., Bergquist J., Nyholm D., Zjablov G., et al. Irreversible motor impairment in young addicts-ephedrone, manganism or both?. Acta Neurologica Scandinavica 2007, 115:385-389.
163. Singleton A.B., Farrer M.J., Bonifati V. The genetics of Parkinson's disease: Progress and therapeutic implications. Movement Disorders 2013, 28:14-23.
164. Slicker J., Vermilyea S. Pediatric parenteral nutrition: Putting the microscope on macronutrients and micronutrients. Nutrition in Clinical Practice 2009, 24:481-486.
165. Spahr L., Butterworth R.F., Fontaine S., Bui L., Therrien G., Milette P.C., et al. Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996, 24:1116-1120.
166. Spranger M., Schwab S., Desiderato S., Bonmann E., Krieger D., Fandrey J. Manganese augments nitric oxide synthesis in murine astrocytes: A new pathogenetic mechanism in manganism?. Experimental Neurology 1998, 149:277-283.
167. Squitti R., Gorgone G., Panetta V., Lucchini R., Bucossi S., Albini E., et al. Implications of metal exposure and liver function in Parkinsonian patients resident in the vicinities of ferroalloy plants. Journal of Neural Transmission 2009, 116:1281-1287.
168. Sreedharan S., Stephansson O., Schioth H.B., Fredriksson R. Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters. Gene 2011, 478:11-18.
169. Sriram K., Lin G.X., Jefferson A.M., Roberts J.R., Chapman R.S., Chen B.T., et al. Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes. Archives of Toxicology 2010, 84:521-540.
170. Sriram K., Lin G.X., Jefferson A.M., Roberts J.R., Wirth O., Hayashi Y., et al. Mitochondrial dysfunction and loss of Parkinson's disease-linked proteins contribute to neurotoxicity of manganese-containing welding fumes. FASEB Journal 2010, 24:4989-5002.
171. Stamelou M., Tuschl K., Chong W.K., Burroughs A.K., Mills P.B., Bhatia K.P., et al. Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: A new treatable disorder. Movement Disorders 2012, 27:1317-1322.
172. Stepens A., Logina I., Liguts V., Aldins P., Eksteina I., Platkajis A., et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. New England Journal of Medicine 2008, 358:1009-1017.
173. Stephenson A.P., Schneider J.A., Nelson B.C., Atha D.H., Jain A., Soliman K.F., et al. Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: Attenuation of thymine base lesions by glutathione and N-acetylcysteine. Toxicology Letters 2013, 218:299-307.
174. Sue W.C., Chen C.Y., Chen C.C. Dyskinesia from manganism in a hepatic dysfunction patient. Zhonghua Minguo Guo Xiao Er Ke Yi Xue Hui Za Zhi 1996, 37:59-64.
175. Takeda A., Sawashita J., Okada S. Manganese concentration in rat brain: Manganese transport from the peripheral tissues. Neuroscience Letters 1998, 242:45-48.
176. Tan J., Zhang T., Jiang L., Chi J., Hu D., Pan Q., et al. Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein. Journal of Biological Chemistry 2011, 286:29654-29662.
177. Tuschl K., Clayton P.T., Gospe S.M., Gulab S., Ibrahim S., Singhi P., et al. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. American Journal of Human Genetics 2012, 90:457-466.
178. Tuschl K., Clayton P.T., Gospe S.M., Mills P.B. Dystonia/parkinsonism, hypermanganesemia, polycythemia, and chronic liver disease. GeneReviews™ [Internet] 1993, University of Washington, Seattle, WA.
179. Tuschl K., Mills P.B., Parsons H., Malone M., Fowler D., Bitner-Glindzicz M., et al. Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia-A new metabolic disorder. Journal of Inherited Metabolic Disease 2008, 31:151-163.
180. Tussing-Humphreys L., Pusatcioglu C., Nemeth E., Braunschweig C. Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: Introducing hepcidin. Journal of the Academy of Nutrition and Dietetics 2012, 112:391-400.
181. Van B.K., Dode L., Vanoevelen J., Callewaert G., De S.H., Missiaen L., et al. The Ca2+/Mn2+ pumps in the Golgi apparatus. Biochimica et Biophysica Acta 2004, 1742:103-112.
182. 2+ ions. Journal of Biological Chemistry 2005, 280:22800-22808.
183. Wang C.Y., Jenkitkasemwong S., Duarte S., Sparkman B.K., Shawki A., Mackenzie B., et al. ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading. Journal of Biological Chemistry 2012, 287:34032-34043.
184. Wang J., Rahman M.F., Duhart H.M., Newport G.D., Patterson T.A., Murdock R.C., et al. Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 2009, 30:926-933.
185. Wang X.S., Ong W.Y., Connor J.R. A light and electron microscopic study of the iron transporter protein DMT-1 in the monkey cerebral neocortex and hippocampus. Journal of Neurocytology 2001, 30:353-360.
186. Wedler F.C., Vichnin M.C., Ley B.W., Tholey G., Ledig M., Copin J.C. Effects of Ca(II) ions on Mn(II) dynamics in chick glia and rat astrocytes: Potential regulation of glutamine synthetase. Neurochemical Research 1994, 19:145-151.
187. Weissenborn K., Ehrenheim C., Hori A., Kubicka S., Manns M.P. Pallidal lesions in patients with liver cirrhosis: Clinical and MRI evaluation. Metabolic Brain Disease 1995, 10:219-231.
188. Willis A.W., Evanoff B.A., Lian M., Galarza A., Wegrzyn A., Schootman M., et al. Metal emissions and urban incident Parkinson disease: A community health study of Medicare beneficiaries by using geographic information systems. American Journal of Epidemiology 2010, 172:1357-1363.
189. Witzleben C.L., Pitlick P., Bergmeyer J., Benoit R. Acute manganese overload. A new experimental model of intrahepatic cholestasis. American Journal of Pathology 1968, 53:409-422.
190. 2+, Mn(2+)-ATPase, hSPCA2, has unusual properties and is expressed in the brain. Journal of Biological Chemistry 2005, 280:11608-11614.
191. Xu Z.W., Li Y.S. Pathogenesis and treatment of parenteral nutrition-associated liver disease. Hepatobiliary & Pancreatic Diseases International 2012, 11:586-593.
192. Yamada M., Ohno S., Okayasu I., Okeda R., Hatakeyama S., Watanabe H., et al. Chronic manganese poisoning: A neuropathological study with determination of manganese distribution in the brain. Acta Neuropathologica 1986, 70:273-278.
193. Yin Z., Jiang H., Lee E.S., Ni M., Erikson K.M., Milatovic D., et al. Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. Journal of Neurochemistry 2010, 112:1190-1198.
194. Yokel R.A. Manganese flux across the blood-brain barrier. Neuromolecular Medicine 2009, 11:297-310.
195. Yokel R.A., Crossgrove J.S. Manganese toxicokinetics at the blood-brain barrier. Research Report. Health Effects Institute 2004, 119:7-58.
196. Yoon H., Kim D.S., Lee G.H., Kim K.W., Kim H.R., Chae H.J. Apoptosis induced by manganese on neuronal SK-N-MC cell line: Endoplasmic reticulum (ER) stress and mitochondria dysfunction. Environmental Health and Toxicology 2011, 26:e2011017.